Nanotechnology makes use of biotechnology

Nanotechnology applications are pushing the boundaries of a number of sectors including electronics. New research in the field of microelectronics facilitates the manufacture of nanodevices at the molecular level based on the use of genetic material.

The EC-funded MINT project focused on the level of interconnections that can be achieved in the new generation of nanodevices. The aim was to achieve at least the same level of interconnections as those in microelectronic systems. Project partners investigated the potential role of ribonucleic acid (RNA) as part of the manufacturing process of original templates.

RNA folds into specific tertiary structures giving researchers the opportunity to exploit this property in order to form new templates for the design of novel nanodevices. Within the framework of MINT, the University of Liverpool designed and characterised a series of self-assembling RNA molecules for the purposes of nanofabrication.

These RNA structures combine either in twos or in fours to form one-dimensional fibres in the presence of magnesium ions. These structures have been designed to facilitate specific and non-specific attachment of RNA molecules to gold nanoparticles, electrodes or surfaces. The resulting RNA-gold fibres have been used successfully as templates for electrochemical deposition of metal on gold surfaces. The aim is to form nanointerconnections between the varied components.

The University is seeking further support to continue this line of research. The applications of this project could have a profound effect on the field of nanotechnology and in particular in the area of nanoelectronics.

Contact Details
BATES, Andy (Dr)
University of Liverpool
Lecturer in Molecular Biology
School of Biological Sciences
L69 7ZB
Liverpool
UNITED KINGDOM
Tel: +44-1517-954563
Fax: +44-1517-954410
URL: http://www.liv.ac.uk/bio/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...